The clinical and pharmacological rationale of using intraperitoneal (IP) chemotherapy has been demonstrated in randomized clinical trials. However, IP chemotherapy is often discontinued secondary to catheter-related complications such as blockage, leakage, infection, and access difficulties. An effective method that provides a reliable access to the IP cavity is needed. In this report, we describe a novel technique of IP port placement that may prevent access problems and decrease patient discomfort.
View details for DOI 10.1002/jso.20255
View details for Web of Science ID 000229453300006
View details for PubMedID 15906367